ID   SNRK_HUMAN              Reviewed;         765 AA.
AC   Q9NRH2; B2RAV6; Q14706; Q68D15; Q6IQ46; Q9NXI7;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   05-OCT-2010, entry version 79.
DE   RecName: Full=SNF-related serine/threonine-protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=SNF1-related kinase;
GN   Name=SNRK; Synonyms=KIAA0096, SNFRK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND AUTOPHOSPHORYLATION.
RX   MEDLINE=22220112; PubMed=12234663; DOI=10.1016/S0378-1119(02)00829-6;
RA   Kertesz N., Samson J., Debacker C., Wu H., Labastie M.-C.;
RT   "Cloning and characterization of human and mouse SNRK sucrose non-
RT   fermenting protein (SNF-1)-related kinases.";
RL   Gene 294:13-24(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-173, AND MUTAGENESIS OF THR-173.
RX   PubMed=15733851; DOI=10.1016/j.febslet.2005.01.042;
RA   Jaleel M., McBride A., Lizcano J.M., Deak M., Toth R., Morrice N.A.,
RA   Alessi D.R.;
RT   "Identification of the sucrose non-fermenting related kinase SNRK, as
RT   a novel LKB1 substrate.";
RL   FEBS Lett. 579:1417-1423(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   MEDLINE=95308325; PubMed=7788527; DOI=10.1093/dnares/2.1.37;
RA   Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S.,
RA   Tabata S., Ishikawa K., Kawarabayasi Y., Kotani H., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. III.
RT   The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:37-43(1995).
RN   [4]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland;
RA   Li Y., Wu T., Xu S., Ren S., Chen Z., Han Z.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Colon mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=96184553; PubMed=8654423;
RX   DOI=10.1111/j.1432-1033.1996.00736.x;
RA   Becker W., Heukelbach J., Kentrup H., Joost H.G.;
RT   "Molecular cloning and characterization of a novel mammalian protein
RT   kinase harboring a homology domain that defines a subfamily of
RT   serine/threonine kinases.";
RL   Eur. J. Biochem. 235:736-743(1996).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-607, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-260; SER-391; SER-611; LEU-748 AND
RP   MET-765.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in hematopoietic cell proliferation or
CC       differentiation. Potential mediator of neuronal apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-173 by
CC       STK11 in complex with STE20-related adapter-alpha (STRAD alpha)
CC       pseudo kinase and CAB39.
CC   -!- INTERACTION:
CC       O75716:STK16; NbExp=1; IntAct=EBI-1053132, EBI-749295;
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRH2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRH2-2; Sequence=VSP_051959, VSP_051960;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in hematopoietic progenitor cells
CC       and leukemic cell lines. Weakly expressed in the testis.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07744.2; Type=Erroneous initiation;
CC       Sequence=CAH18415.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D43636; BAA07744.2; ALT_INIT; mRNA.
DR   EMBL; AF226044; AAF86944.1; -; mRNA.
DR   EMBL; AK000231; BAA91023.1; -; mRNA.
DR   EMBL; AK314376; BAG37003.1; -; mRNA.
DR   EMBL; CR749621; CAH18415.1; ALT_INIT; mRNA.
DR   EMBL; CH471055; EAW64693.1; -; Genomic_DNA.
DR   EMBL; BC071567; AAH71567.1; -; mRNA.
DR   IPI; IPI00470811; -.
DR   IPI; IPI00718873; -.
DR   RefSeq; NP_001094064.1; -.
DR   RefSeq; NP_060189.3; -.
DR   UniGene; Hs.476052; -.
DR   ProteinModelPortal; Q9NRH2; -.
DR   SMR; Q9NRH2; 14-333.
DR   IntAct; Q9NRH2; 2.
DR   MINT; MINT-1338450; -.
DR   STRING; Q9NRH2; -.
DR   PhosphoSite; Q9NRH2; -.
DR   PRIDE; Q9NRH2; -.
DR   Ensembl; ENST00000296088; ENSP00000296088; ENSG00000163788.
DR   Ensembl; ENST00000429705; ENSP00000411375; ENSG00000163788.
DR   Ensembl; ENST00000454177; ENSP00000401246; ENSG00000163788.
DR   GeneID; 54861; -.
DR   KEGG; hsa:54861; -.
DR   UCSC; uc003cms.2; human.
DR   UCSC; uc003cmu.2; human.
DR   CTD; 54861; -.
DR   GeneCards; GC03P043303; -.
DR   H-InvDB; HIX0003216; -.
DR   HGNC; HGNC:30598; SNRK.
DR   MIM; 612760; gene.
DR   PharmGKB; PA142670894; -.
DR   HOGENOM; HBG714941; -.
DR   HOVERGEN; HBG093970; -.
DR   InParanoid; Q9NRH2; -.
DR   OMA; TYSWHRR; -.
DR   OrthoDB; EOG91C9FW; -.
DR   PhylomeDB; Q9NRH2; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 57744; -.
DR   ArrayExpress; Q9NRH2; -.
DR   Bgee; Q9NRH2; -.
DR   CleanEx; HS_SNRK; -.
DR   Genevestigator; Q9NRH2; -.
DR   GermOnline; ENSG00000163788; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR020661; SNF-rel_Ser/Thr_prot_kinase.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF47; SNF-rel_Ser/Thr_prot_kinase; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    765       SNF-related serine/threonine-protein
FT                                kinase.
FT                                /FTId=PRO_0000225605.
FT   DOMAIN       16    269       Protein kinase.
FT   DOMAIN      291    334       UBA.
FT   NP_BIND      22     30       ATP (By similarity).
FT   ACT_SITE    139    139       Proton acceptor (By similarity).
FT   BINDING      45     45       ATP (By similarity).
FT   MOD_RES      11     11       N6-acetyllysine.
FT   MOD_RES     173    173       Phosphothreonine.
FT   MOD_RES     390    390       Phosphoserine.
FT   MOD_RES     569    569       Phosphoserine (By similarity).
FT   MOD_RES     607    607       Phosphoserine.
FT   VAR_SEQ     244    244       D -> E (in isoform 2).
FT                                /FTId=VSP_051959.
FT   VAR_SEQ     245    765       Missing (in isoform 2).
FT                                /FTId=VSP_051960.
FT   VARIANT     260    260       L -> S (in dbSNP:rs35624204).
FT                                /FTId=VAR_041096.
FT   VARIANT     391    391       P -> S (in dbSNP:rs56104180).
FT                                /FTId=VAR_041097.
FT   VARIANT     611    611       G -> S (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041098.
FT   VARIANT     748    748       P -> L (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041099.
FT   VARIANT     765    765       I -> M (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041100.
FT   MUTAGEN     173    173       T->A,E: Prevents phosphorylation and
FT                                activation by STK11 complex.
FT   CONFLICT     97     97       G -> E (in Ref. 5; AAF86944).
FT   CONFLICT    116    116       A -> P (in Ref. 5; AAF86944).
FT   CONFLICT    124    124       V -> A (in Ref. 7; CAH18415).
FT   CONFLICT    181    181       S -> P (in Ref. 7; CAH18415).
FT   CONFLICT    196    196       V -> A (in Ref. 7; CAH18415).
FT   CONFLICT    211    211       G -> E (in Ref. 6; BAA91023).
FT   CONFLICT    219    219       N -> D (in Ref. 7; CAH18415).
FT   CONFLICT    259    259       S -> Y (in Ref. 9; AAH71567).
FT   CONFLICT    445    445       V -> A (in Ref. 7; CAH18415).
FT   CONFLICT    482    482       S -> G (in Ref. 7; CAH18415).
FT   CONFLICT    486    486       L -> V (in Ref. 9; AAH71567).
FT   CONFLICT    636    636       A -> V (in Ref. 7; CAH18415).
FT   CONFLICT    722    722       K -> R (in Ref. 9; AAH71567).
SQ   SEQUENCE   765 AA;  84276 MW;  06EF88CF7F8A393D CRC64;
     MAGFKRGYDG KIAGLYDLDK TLGRGHFAVV KLARHVFTGE KVAVKVIDKT KLDTLATGHL
     FQEVRCMKLV QHPNIVRLYE VIDTQTKLYL ILELGDGGDM FDYIMKHEEG LNEDLAKKYF
     AQIVHAISYC HKLHVVHRDL KPENVVFFEK QGLVKLTDFG FSNKFQPGKK LTTSCGSLAY
     SAPEILLGDE YDAPAVDIWS LGVILFMLVC GQPPFQEAND SETLTMIMDC KYTVPSHVSK
     ECKDLITRML QRDPKRRASL EEIENHPWLQ GVDPSPATKY NIPLVSYKNL SEEEHNSIIQ
     RMVLGDIADR DAIVEALETN RYNHITATYF LLAERILREK QEKEIQTRSA SPSNIKAQFR
     QSWPTKIDVP QDLEDDLTAT PLSHATVPQS PARAADSVLN GHRSKGLCDS AKKDDLPELA
     GPALSTVPPA SLKPTASGRK CLFRVEEDEE EDEEDKKPMS LSTQVVLRRK PSVTNRLTSR
     KSAPVLNQIF EEGESDDEFD MDENLPPKLS RLKMNIASPG TVHKRYHRRK SQGRGSSCSS
     SETSDDDSES RRRLDKDSGF TYSWHRRDSS EGPPGSEGDG GGQSKPSNAS GGVDKASPSE
     NNAGGGSPSS GSGGNPTNTS GTTRRCAGPS NSMQLASRSA GELVESLKLM SLCLGSQLHG
     STKYIIDPQN GLSFSSVKVQ EKSTWKMCIS STGNAGQVPA VGGIKFFSDH MADTTTELER
     IKSKNLKNNV LQLPLCEKTI SVNIQRNPKE GLLCASSPAS CCHVI
//
